Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18383123 | 1.00 | AKR1B1 (0.33) | AKR1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL16915296 | 0.87 | LMNA (0.40) | AKR1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL19512303 | 0.87 | LMNA (0.40) | AKR1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL3645294 | 0.87 | LMNA (0.40) | AKR1B1LMNAL3MBTL1TDP1 | |
| Furan SCHEMBL28235587 | 0.86 | — | — | |
| SCHEMBL19690615 | 0.83 | AKR1B1 (0.31) | AKR1B1 | |
| SCHEMBL2598813 | 0.79 | — | — | |
| SCHEMBL4321542 | 0.79 | — | — | |
| SCHEMBL19690518 | 0.78 | — | — | |
| SCHEMBL28275875 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3946448-B1 | SEMI-SYNTHETIC BIOPOLYMERS FOR USE IN STIMULATING THE IMMUNE SYSTEM | IMMUNOPHOTONICS INC (US) | 2025-12-10 | — | — | EP | disclosed |
| US-20250340912-A1 | METHOD FOR PRODUCING 2,4-DIHYDROXY BUTYRATE OR L-THREONINE USING A MICROBIAL METABOLIC PATHWAY | Technische Universität Dresden (DE) | 2025-11-06 | — | — | US | disclosed |
| EP-4637800-A1 | COMPOSITIONS COMPRISING AN ONCOLYTIC PEPTIDE AND CHITOSAN | Lytix Biopharma AS (NO) | 2025-10-29 | — | — | EP | disclosed |
| EP-4637799-A1 | MEDICAL PRODUCTS CONTAINING AN AQUEOUS FORMULATION OF A PEPTIDE | Lytix Biopharma AS (NO) | 2025-10-29 | — | — | EP | disclosed |
| US-12398215-B2 | Chitosan-derived compositions | IMMUNOPHOTONICS, INC (US) | 2025-08-26 | — | — | US | disclosed |
| US-20250134993-A1 | GLYCATED CHITOSANS FOR TREATMENT OF VIRAL INFECTIONS | IMMUNOPHOTONICS, INC. | 2025-05-01 | — | — | US | disclosed |
| US-20250122313-A1 | METHODS FOR PRODUCING GLYCATED CHITOSANS | IMMUNOPHOTONICS, INC | 2025-04-17 | — | — | US | disclosed |
| WO-2025052933-A1 | COMPOSITION, AND COMPOSITIONS FOR VISCOSITY ENHANCEMENT | DIC株式会社 | 2025-03-13 | — | — | WO | disclosed |
| US-12208081-B2 | Tannin-containing gastrointestinal formulations and methods of use | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-01-28 | — | — | US | disclosed |
| WO-2024218102-A1 | MODIFICATION OF AROMATIC POLYMERS | PREFERE RESINS HOLDING GMBH (DE) | 2024-10-24 | — | — | WO | disclosed |
| US-20220160753-A1 | SEMI-SYNTHETIC BIOPOLYMERS FOR USE IN STIMULATING THE IMMUNE SYSTEM | IMMUNOPHOTONICS INC (US) | 2022-05-26 | — | — | US | disclosed |
| EP-3990556-A1 | USE OF POLYPHENOL COMPOUNDS AND HYDROPHILIC POLYMERS FOR REDUCING OR PREVENTING COLLOIDS ADHESION AND/OR FOULING ON A SUBSTRATE | RHODIA OPERATIONS (FR) | 2022-05-04 | — | — | EP | disclosed |
| EP-3946448-A1 | SEMI-SYNTHETIC BIOPOLYMERS FOR USE IN STIMULATING THE IMMUNE SYSTEM | Immunophotonics, Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
| US-20150290227-A1 | USE OF HAMAMELITANNIN FOR THE TREATMENT OF STAPHYLOCOCCAL INFECTIONS | BALABAN NAOMI (US) | 2015-10-15 | — | — | US | disclosed |
| WO-2007147098-A2 | IDENTIFICATION AND USE OF NON-PEPTIDE ANALOGS OF RNAIII-INHIBITING PEPTIDE FOR THE TREATMENT OF STAPHYLOCOCCAL INFECTIONS | TUFTS UNIVERSITY (US) | 2007-12-21 | — | — | WO | disclosed |
| US-20070293435-A1 | Identification and Use of Non-Peptide Analogs of RNAIII-Inhibiting Peptide for the Treatment of Staphylococcal Infections | BALABAN, NAOMI | 2007-12-20 | — | — | US | disclosed |
| US-6562514-B1 | Stabilized vanadium electrolyte solutions for all-vanadium redox cells and batteries | PINNACLE VRB LIMITED (AU) | 2003-05-13 | — | — | US | disclosed |
| US-6468688-B2 | CHARGING, DISCHARGING EFFICIENCY; VANADIUM ELECTROLYTE | PINNACLE VRB LIMITED (AU) | 2002-10-22 | — | — | US | disclosed |
| US-20010028977-A1 | Charging, discharging efficiency; vanadium electrolyte | JD HOLDING INC. (KY) | 2001-10-11 | — | — | US | disclosed |
| US-6143443-A | ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE | PINNACLE ARB LIMITED (AU) | 2000-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12208081-B2 | Tannin-containing gastrointestinal formulations and methods of use | FABP2, FABP6, MLN | AKR1B1 4587/4885LMNA 2812/4885L3MBTL1 4537/4885 |
| US-20220160753-A1 | SEMI-SYNTHETIC BIOPOLYMERS FOR USE IN STIMULATING THE IMMUNE SYSTEM | CD40LG, CD14, CD69 | AKR1B1 4718/4885LMNA 4616/4885L3MBTL1 4647/4885 |
| US-12398215-B2 | Chitosan-derived compositions | CHIT1, CHIA, MUC1 | AKR1B1 4174/4885LMNA 2537/4885L3MBTL1 2512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.